Baramah to Asharq Al-Awsat: Sudan War Lacks Clear Purpose or Justification

Sudan’s National Umma Party Chairperson Fadlallah Baramah (Asharq Al-Awsat)
Sudan’s National Umma Party Chairperson Fadlallah Baramah (Asharq Al-Awsat)
TT

Baramah to Asharq Al-Awsat: Sudan War Lacks Clear Purpose or Justification

Sudan’s National Umma Party Chairperson Fadlallah Baramah (Asharq Al-Awsat)
Sudan’s National Umma Party Chairperson Fadlallah Baramah (Asharq Al-Awsat)

The leader of Sudan’s National Umma Party, Fadlallah Baramah, described the signing of the “Addis Ababa Declaration” between the Civil Democratic Forces Alliance (Tagaddum) and the Rapid Support Forces (RSF) as a “preliminary step on the right path towards peace.”

He deemed it a “political and military opportunity to reach a final resolution for the Sudanese crisis.”

Speaking to Asharq Al-Awsat in the Ethiopian capital, Addis Ababa, Baramah characterized the conflict that erupted in Sudan on April 15, 2023, as distinct from previous wars in the country.

He emphasized, in the remarks published Friday, that this war lacks a clear objective and has surpassed both in human and material losses all preceding conflicts.

Baramah leads one of Sudan’s largest political parties, the National Umma Party, and is a military veteran who previously served as the Northeast African country’s Minister of Defense.

Drawing on his military expertise, Baramah drew comparisons between the current war involving the Sudanese army and the RSF and previous wars.

He pointed out that the South Sudan War, known as the “Torit mutiny” from August 1955 to 1962, concluded with the Addis Ababa Agreement in 1973 led by General Joseph Lagu.

Baramah recalled the history of conflict witnessed by Sudan, including the war led by John Garang de Mabior (1983-2005), the Nuba Mountains War led by Yousif Kuwa and Telfal Kokor (1985), and the Darfur War (2003-2020).

All these conflicts did not result in the same level of loss of life and infrastructure damage as the current war, noted Baramah.

“This war must come to a halt, as it has inflicted unprecedented harm on lives, people, and infrastructure over nine months, unlike any of the previous wars that lasted 51 years,” he asserted.

“Thousands have lost their lives, millions have been displaced and uprooted, and there has been unparalleled destruction to infrastructure – destruction that is challenging to repair.”

“For instance, the destroyed Jili Petroleum Refinery (north of Bahri city in the capital Khartoum) requires five billion dollars for reconstruction (its initial construction cost was two billion dollars), and the Shambat Bridge needs millions, in addition to other private and public facilities,” clarified Baramah.

Baramah observed that the current Sudanese war is “without cause,” unlike the preceding conflicts in Sudan.

“All previous wars had their reasons and justifications, but this war is unjustifiable,” he told Asharq Al-Awsat.

“The South Sudan War, for instance, stemmed from the Southerners’ rightful demand for federal governance and later independence, a legitimate demand. The rest of the wars were about citizens’ rights to wealth and power," explained Baramah.

Expressing concern, Baramah warned about the catastrophic consequences of this war, describing them as perilous.

“This war has brought us to a dangerous stage, marked by the proliferation of hate speech, which is more destructive than the destruction of infrastructure because it leads to the destruction of Sudan,” he cautioned.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.